Clinical Study

Low Hematocrit Is a Strong Predictor of Poor Prognosis in Lung Cancer Patients

Table 1

Baseline characteristics of the 1022 patients.

Clinical featurenPercentage

Sex
 Male59057.7
 Female43242.3
Tumor stage
 I57356.1
 II28327.7
 III16616.2
Age (years)
 <6056455.2
 ≥6045844.8
BMI
 <18.5595.8
 18.5-24.055354.1
 ≥24.041040.1
Smoking status
 No43443.6
 Yes56256.4
Histologic type
 Squamous carcinoma26926.3
 Adenocarcinoma59358.0
 Others16015.7

Note: the numbers in some groups are < 1022 due to the lack of original data. Hb: 1, Hb ≥ 120 g/L for male, ≥110 g/L for female; 2, Hb < 120 g/L for male, <110/L for female. RBC: 1, RBC ≥ 4×1012/L for male, ≥3.5 × 1012/L for female; 2, RBC < 4 × 1012/L for male, <3.5 × 1012/L for female. HCT: 1, HCT ≥ 40% for male, ≥35% for female; 2, HCT < 40% for male, <35% for female. The low group is marked 1, normal group marked 2, and high group marked 3 in each group.